CardioVasc HR, Inc.

Saint-Jean-sur-Richelieu, Quebec J3A1C3

0 studies enrolling now · 7 studies all time

What they study most

Cardiovascular Disease, Cardiovascular Diseases, Cardiovascular Risk, Chronic Heart Failure With Preserved Ejection Fraction, Chronic Kidney Disease, Heart Failure, Heart Failure With Preserved Ejection Fraction, High Cardiovascular Risk, Obesity, Overweight, Transthyretin Amyloid Cardiomyopathy, Type 2 Diabetes

Studies at this site

• A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease — Completed
• A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
• A Study of Ponsegromab in People With Heart Failure — Stopped early
• Levels of Inflammation in People With Cardiovascular Disease (POSEIDON) — Completed
• Global Prevalence of ATTR-CM in Participants With HFpEF — Stopped early
• Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed